Q1 2024 Asensus Surgical Inc Earnings Call Transcript
Key Points
- Asensus Surgical Inc (ASXC) entered into a nonbinding letter of intent with Karl Storz for a potential acquisition, which could provide significant financial and strategic benefits.
- The company reported a slight increase in revenue for Q1 2024 compared to Q1 2023, indicating growth in their operations.
- Asensus Surgical Inc (ASXC) has received financing from Karl Storz, providing them with up to $10 million to support operations during the negotiation period.
- The Senhance system usage grew to nearly 900 procedures worldwide in Q1, showing increasing adoption and utilization of the company's technology.
- New program initiations, like the agreement with Sendai Topics Yuchai Hospital in Japan, demonstrate expanding market trust and adoption of Asensus Surgical Inc (ASXC)'s technology.
- Asensus Surgical Inc (ASXC) reported a net loss of $22.5 million in Q1 2024, indicating ongoing financial challenges.
- Despite slight revenue growth, the company's operating expenses increased from the previous year, contributing to the net loss.
- The potential acquisition by Karl Storz is still uncertain, with no definitive agreement currently in place.
- The company's cash reserves, excluding the recent financing, are only sufficient to sustain operations into Q3 2024, highlighting a potential risk of running out of funds if additional financing is not secured.
- The ongoing due diligence and negotiation processes with Karl Storz may divert focus and resources from other operational priorities.
Good afternoon, ladies and gentlemen, and welcome to the Sensus surgical first quarter financial and operating results call. At this time, all lines are in a listen only mode. Following the presentation we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Tuesday, May 14th, 2024.
I would now like to turn the conference over to Mark Klausner from Westwicke Partners. Please go ahead.
Good afternoon, everyone, and thank you for joining us for the Sensus surgical first quarter business and financial update conference call. On the call with me today are Anthony Fernando, President and Chief Executive Officer, and she means rand per cab, Chief Financial Officer.
Before we begin, I would like to caution listeners that certain information discussed by management during this conference call, including any guidance provided are forward-looking statements provided
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
